Lakefront Biotherapeutics N.V. (LKFT) Stock Ticker
LKFT right now
Market factors today
Unlock the full LKFT picture
About Lakefront Biotherapeutics N.V.
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.
LKFT stock facts
| Ticker symbol | LKFT |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.9B |
| CEO | Henry O. Gosebruch |
| Employees | 452 |
| Headquarters | Mechelen, BE |
| IPO date | 2005-05-05 |
| Website | lakefrontbio.com |
What you can see for LKFT on Tickr
Live LKFT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LKFT report.
Rankings
FAQ
What is the ticker symbol for Lakefront Biotherapeutics N.V.?
The ticker symbol for Lakefront Biotherapeutics N.V. is LKFT, listed on the NASDAQ Global Select.
What is LKFT?
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by…